| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/22/2002 | CA2043709C Antimigraine alkoxypyrimidine derivatives |
| 01/22/2002 | CA2038848C Hydantoin derivatives |
| 01/22/2002 | CA2028909C Preparation of intermediates and the synthesis of n-(2-hydroxy-ethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidines |
| 01/22/2002 | CA2027876C Use of substituted imidazoles |
| 01/21/2002 | CA2353369A1 Novel heteroaryl derivatives and their use as medicaments |
| 01/21/2002 | CA2353360A1 Novel heteroaryl derivatives and their use as medicaments |
| 01/21/2002 | CA2353353A1 Novel heteroaryl derivatives and their use as medicaments |
| 01/20/2002 | CA2358356A1 Pharmaceutical composition containing citalopram |
| 01/19/2002 | CA2315815A1 Topical pain relief composition and carrier |
| 01/17/2002 | WO2002004952A2 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
| 01/17/2002 | WO2002004626A1 Fungal cell wall synthesis gene |
| 01/17/2002 | WO2002004623A2 ANTISENSE COMPOSITIONS TARGETED TO β1 ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE |
| 01/17/2002 | WO2002004605A2 Stimulation of cellular regeneration and differentiation in the inner ear |
| 01/17/2002 | WO2002004531A2 Process for preparing benzoxazin-4-one polymer conjugates |
| 01/17/2002 | WO2002004511A2 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 01/17/2002 | WO2002004485A1 Haemagglutinin antigen |
| 01/17/2002 | WO2002004474A1 Adenosine compound and pharmaceutical composition containing the same |
| 01/17/2002 | WO2002004472A1 Novel compounds and methods |
| 01/17/2002 | WO2002004471A1 Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 01/17/2002 | WO2002004467A1 Novel cytotoxic compounds and their use |
| 01/17/2002 | WO2002004464A1 Novel cephalosporin compounds and process for preparing the same |
| 01/17/2002 | WO2002004463A1 Novel cephalosporin compounds and process for preparing the same |
| 01/17/2002 | WO2002004462A1 Oxazinoquinolones useful for the treatment of viral infections |
| 01/17/2002 | WO2002004461A1 Hydropyridine derivative acid addition salts |
| 01/17/2002 | WO2002004459A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 01/17/2002 | WO2002004457A1 Azepino[4,5-b]pyrano[3,2-e]indoles |
| 01/17/2002 | WO2002004456A1 SUBSTITUTED 2,3,7,8,9,10,11,12-OCTAHYDROAZEPINO[4,5-b]PYRANO[3,2-e]INDOLES |
| 01/17/2002 | WO2002004455A2 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 01/17/2002 | WO2002004452A2 Methods for treatment of disease-induced peripheral neuropathy and related conditions |
| 01/17/2002 | WO2002004451A2 Methods for stimulation of synthesis of synaptophysin in the central nervous system |
| 01/17/2002 | WO2002004449A2 Methods for treatment of conditions affected by activity of multidrug transporters |
| 01/17/2002 | WO2002004448A2 Methods for treatment of drug-induced peripheral neuropathy and related conditions |
| 01/17/2002 | WO2002004447A1 Variolin derivatives as anti-cancer agents |
| 01/17/2002 | WO2002004446A1 New bispidine compounds and their use in the treatment of cardiac arrhythmias |
| 01/17/2002 | WO2002004445A1 Heterocycle carboxamides as antiviral agents |
| 01/17/2002 | WO2002004444A2 Heterocycle carboxamides as antiviral agents |
| 01/17/2002 | WO2002004443A2 Heterocycle carboxamides as antiviral agents |
| 01/17/2002 | WO2002004440A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 01/17/2002 | WO2002004439A2 Thiophene retinoids |
| 01/17/2002 | WO2002004437A1 Obesity inhibitory materials |
| 01/17/2002 | WO2002004434A1 Colchinol derivatives as vascular damaging agents |
| 01/17/2002 | WO2002004433A2 Melanin concentrating hormone receptor ligands |
| 01/17/2002 | WO2002004429A1 Pyrimidine derivatives |
| 01/17/2002 | WO2002004427A1 Phenylpyridazine derivatives and drugs containing the same |
| 01/17/2002 | WO2002004426A1 Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
| 01/17/2002 | WO2002004425A2 Viral polymerase inhibitors |
| 01/17/2002 | WO2002004424A1 Pyrazole derivatives |
| 01/17/2002 | WO2002004423A1 Thrombin inhibitors comprising an aminoisoquinoline group |
| 01/17/2002 | WO2002004422A2 Heterocycle carboxamides as antiviral agents |
| 01/17/2002 | WO2002004421A2 Pyridoxine and pyridoxal analogues: cardiovascular therapeutics |
| 01/17/2002 | WO2002004420A1 Piperidine coumpounds for use as ccr-3 inhibitors |
| 01/17/2002 | WO2002004414A1 Pleuromutilin derivatives having antibacterial activity |
| 01/17/2002 | WO2002004412A2 Tyrosine derivatives as phosphatase inhibitors |
| 01/17/2002 | WO2002004407A2 7-substituted tetracycline compounds |
| 01/17/2002 | WO2002004406A2 9-substituted minocycline compounds |
| 01/17/2002 | WO2002004405A2 13-substituted methacycline compounds |
| 01/17/2002 | WO2002004404A2 7,8 and 9-substituted tetracycline compounds |
| 01/17/2002 | WO2002004034A2 Polymer-bound metal-containing compositions |
| 01/17/2002 | WO2002004031A1 Compositions and methods for treating cardiovascular disorders |
| 01/17/2002 | WO2002004025A1 Production, stabilisation and use of reduced forms of pharmaceutical compounds |
| 01/17/2002 | WO2002004021A1 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications |
| 01/17/2002 | WO2002004006A2 Method for improving the efficacy of artificial insemination of non-human animals |
| 01/17/2002 | WO2002004003A2 Composition for the treatment of osteoarthritis |
| 01/17/2002 | WO2002004000A1 Potent immunostimulants from microalgae |
| 01/17/2002 | WO2002003999A1 High molecular weight polysaccharide fraction from aloe vera with immunostimulatory activity |
| 01/17/2002 | WO2002003998A2 Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| 01/17/2002 | WO2002003997A1 Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides |
| 01/17/2002 | WO2002003996A1 Use of dammarane-type tritepenoid saporins |
| 01/17/2002 | WO2002003995A2 Treatment of male sexual dysfunction |
| 01/17/2002 | WO2002003994A1 N sulfonyl aminoacid derivatives as inhibitors of metalloproteinase |
| 01/17/2002 | WO2002003993A2 Use of inhibitors to multidrug resistance protein 5 (mrp5) to enhance intracellular levels of cyclic nucleotides |
| 01/17/2002 | WO2002003992A2 Use of substituted indole compounds for treating prosthesis-related bone degeneration |
| 01/17/2002 | WO2002003991A2 Use of substituted indole compounds for increasing nitric oxide synthase activity |
| 01/17/2002 | WO2002003990A2 Use of substituted insole compounds for treating excessive intraocular pressure |
| 01/17/2002 | WO2002003989A2 Use of substituted indole compounds for treating sphincter incontinence |
| 01/17/2002 | WO2002003988A2 Use of substituted indole compounds for treating neuropeptide y-related conditions |
| 01/17/2002 | WO2002003987A2 Pharmaceutical compositions of estrogenic agents |
| 01/17/2002 | WO2002003986A2 Use of substituted indole compounds for treating breast disorders |
| 01/17/2002 | WO2002003985A1 Method of modulating expression of ldl-receptor-related protein and uses thereof |
| 01/17/2002 | WO2002003984A2 Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x |
| 01/17/2002 | WO2002003983A1 Fatty acid analogues for the treatment of cancer |
| 01/17/2002 | WO2002003982A1 Antimycotic pharmaceutical |
| 01/17/2002 | WO2002003980A1 Anti-inflammatory and analgesic agents |
| 01/17/2002 | WO2002003979A2 Combination of 2-methoxyestradiol and an agent that increases intracellular superoxide anion |
| 01/17/2002 | WO2002003978A2 A COMBINATION OF FBPase INHIBITORS AND ANTIDIABETIC AGENTS USEFUL FOR THE TREATMENT OF DIABETES |
| 01/17/2002 | WO2002003977A2 Combinations of statins, estrogenic agents and optionally estrogens |
| 01/17/2002 | WO2002003976A2 Combinations of bisphosphonates, estrogenic agents and optionally estrogens |
| 01/17/2002 | WO2002003975A2 Combinations of ssri and estrogenic agents |
| 01/17/2002 | WO2002003973A2 Compositions comprising isosorbide dinitrate and methods for treatment of anal fissure |
| 01/17/2002 | WO2002003972A2 Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds |
| 01/17/2002 | WO2002003971A2 Pharmaceutical composition and method for the treatment of retroviral infections |
| 01/17/2002 | WO2002003965A1 Method for formulating healthcare products with enhanced stability |
| 01/17/2002 | WO2002003964A1 Oral pharmaceutical composition with controlled release and prolonged absorption |
| 01/17/2002 | WO2002003963A1 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic acid as active ingredient |
| 01/17/2002 | WO2002003962A2 Drug delivery system for poorly water soluble drugs |
| 01/17/2002 | WO2002003960A1 Particulate vectors for improving oral absorption of active principles |
| 01/17/2002 | WO2002003958A1 Novel aerosol formulation containing a polar fluorinated molecule |
| 01/17/2002 | WO2002003957A2 Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same |
| 01/17/2002 | WO2002003945A1 Use of oligosaccharides to stimulate beta-endorphin production |
| 01/17/2002 | WO2002003944A1 Composition comprising a ceramide precursor for improving natural or reconstructed epidermis, resulting skin equivalent |